New top UK research institute gets £3 million boost:
This article was originally published in Clinica
The University of Edinburgh has secured £38 million ($54 million) of the £50 million target funding for what promises to be a unique medical research institute, after the Wolfson Foundation last month pledged £4 million. The provisionally-named Research Institute for Medical Cell Biology, billed as the UK's first facility of its kind, will specialise in cardiovascular, reproductive and inflammatory diseases. Since securing half of the target funding by July 2001 (see Clinica No 965, p 8) it has also received £3 million from the Medical Research Council. It is due to open in 2004.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.